GlassScriptPhysician profile
Mohammad-Asad Ilahi
NPI 1013407105
$10,460.64
in general payments reported to CMS, 2019-2025
18 companies · $431 in 2025
The $431 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $238 · 2022: $7,528 · 2023: $1,628 · 2024: $636 · 2025: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,617 · Travel and Lodging: $1,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,616.75 |
| Travel and Lodging | $1,078.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $7,999.66 | 2022-2023 | |
| Stryker Corporation | $526.65 | 2021-2025 | Prostep Mica, N/A, Augment Injectable |
| Arthrex, INC. | $462.48 | 2023 | |
| Integra Lifesciences Corporation | $341.40 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Averitas Pharma INC. | $279.75 | 2024-2025 | Qutenza |
| Treace Medical Concepts, INC. | $242.62 | 2022-2025 | |
| Smith+Nephew, INC. | $135.79 | 2021-2023 | Grafix Pl, Stravix, Stravix Pl |
| Depuy Synthes Sales INC. | $114.84 | 2022-2023 | Motoband |
| Axogen | $94.51 | 2022-2023 | Avance Nerve Graft |
| Horizon Therapeutics Plc | $56.32 | 2021-2022 | |
| Kerecis Limited | $48.35 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Paratek Pharmaceuticals, INC. | $40.86 | 2022-2023 | Nuzyra |
| Musculoskeletal Transplant Foundation INC. | $27.69 | 2024 | |
| Cashflow Solutions, LLC | $22.52 | 2022 | |
| Abbvie INC. | $20.79 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $18.59 | 2023 | Hymovis, Triluron |
| Mission Medical Distribution, LLC | $16.38 | 2025 | |
| Orthofix Medical, INC. | $11.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad-Asad Ilahi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.